1. The anti-cancer effects and mechanisms of lactic acid bacteria exopolysaccharides in vitro: A review.
- Author
-
Wu J, Zhang Y, Ye L, and Wang C
- Subjects
- Angiogenesis Inhibitors pharmacology, Animals, Anti-Inflammatory Agents pharmacology, Antimutagenic Agents pharmacology, Antineoplastic Agents pharmacology, Antioxidants pharmacology, Apoptosis drug effects, Cell Cycle Checkpoints drug effects, Food Microbiology, Humans, Polysaccharides, Bacterial pharmacology, Probiotics pharmacology, Angiogenesis Inhibitors therapeutic use, Anti-Inflammatory Agents therapeutic use, Antimutagenic Agents therapeutic use, Antineoplastic Agents therapeutic use, Antioxidants therapeutic use, Lactobacillales metabolism, Neoplasms diet therapy, Polysaccharides, Bacterial therapeutic use, Probiotics therapeutic use
- Abstract
Probiotic lactic acid bacteria (LAB) are a particular group of gram-positive bacteria that are usually involved in natural ferments and widely used in food manufacture industry. Most of them can produce exopolysaccharides (EPS), surface carbohydrate polymers with diverse biological functions. LAB EPS are potentially complementary and alternative medicines against cancer. EPS show anti-proliferative effects on a variety of tumor cells from intestine, liver, breast, etc. They modulate the development of tumors through various mechanisms including promoting apoptosis, inducing cell cycle arrest as well as anti-mutagenic, anti-oxidative, anti-angiogenesis and anti-inflammatory effects. Bacterial origin, existence form, chemical structure, purity et al. are important factors affecting the anticancer effects of EPS. The future challenge lies in elucidating the precise structure-function relationship of LAB EPS. Besides, more in vivo studies and further clinical trials are indispensable to confirm the anticancer effects., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF